NEWS LIST
- 01 June 2010 Make harder tablets and protect it from humidity by adding 2% Neusilin® UFL2 to a lactose or mannitol formulation
- 01 December 2008 Solve Tabletting Issues of Alpha Lipoic Acid with Neusilin® US2
- 01 November 2008 Ball Milling of Indomethacin with Neusilin® US2 to Enhance Solubility and Dissolution
- 01 August 2008 Neusilin® Increased Production of Oyster Mushroom on Addition of Neusilin FH1
- 01 July 2008 Neusilin® Increased Bioavailability and Improved Stability of Dihydrine Derivatives with Neusilin US2 for Hard Capsules
- 01 June 2008 Formulation of Sodium Valproate Tablets with Neusilin®
- 01 May 2008 Neusilin® US2, Problem Solver Excipient for Oily API's
- 01 November 2007 The Extraordinary Excipient for Oral Solid Dosage Forms (Formulation With Neusilin® US2)
- 01 October 2007 The Extraordinary Excipient for Oral Solid Dosage Forms (Neusilin's Typical Properties)
You need the free Adobe Acrobat to view the PDFs. Download it here.
News
Make harder tablets and protect it from humidity by adding 2% Neusilin® UFL2 to a lactose or mannitol formulation
In this newsletter, we present application of Neusilin® as multifunctional excipient in Lactose and Mannitol formulations. Neusilin® facilitated production of harder tablets and maintained tablet hardness under accelerated stability conditions.
Solve Tabletting Issues of Alpha Lipoic Acid with Neusilin® US2
In this newsletter, we present a successful formula for preparing high quality tablets of ALA with our multifunctional excipient Neusilin®.
Read more (PDF)
Ball Milling of Indomethacin with Neusilin® US2 to Enhance Solubility and Dissolution
In this newsletter, we introduce published articles by Gupta and Bhal et al; wherein dissolution of indomethacin was markedly improved by co-grinding with Neusilin® US2.
Read more (PDF)
Neusilin® Increased Production of Oyster Mushroom on Addition of Neusilin FH1
In this newsletter, we describe a novel use of Neusilin® where addition of small amounts to the culture media increases mushroom cultivation yields.
Read more (PDF)
Neusilin® Increased Bioavailability and Improved Stability of Dihydrine Derivatives with Neusilin US2 for Hard Capsules
In this newsletter, we refer to a patent published by the European patent office in 1991 (Publication no. 0448091A2) where the authors provide a solution to the above problem by formulating the dihydropyridine derivatives into a non-micelle composition by adding a fatty acid monoglyceride and/or a polyoxyethylenesorbitan fatty acid ester and absorbing further on to a porous inorganic carrier like Neusilin®.
Read more (PDF)
Formulation of Sodium Valproate Tablets with Neusilin®
In this newsletter, we refer to a patent published in Japan in 1987 (Shou 62-81309) where Neusilin® was successfully used to formulate sustained release sodium valproate tablets with excellent stability.
Read more (PDF)
Neusilin® US2, Problem Solver Excipient for Oily API's
In this newsletter, we demonstrate the prowess of Neusilin® US2 in solving the problems related to oily nature of API's when compared to other common excipients.
Read more (PDF)
The Extraordinary Excipient for Oral Solid Dosage Forms (Formulation With Neusilin® US2)
In this newsletter we introduce you to the best disintegrant combination with Neusilin® US2 for tabletting.
Read more (PDF)
The Extraordinary Excipient for Oral Solid Dosage Forms (Neusilin's Typical Properties)
In this newsletter, we highlight the oil adsorption capacity and flow enhancing properties of two of our best grades in the market.
Read more (PDF)
